# Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection.

> **NCT00502086** · PHASE3 · COMPLETED · sponsor: **Catalysis SL** · enrollment: 100 (actual)

## Conditions studied

- Cirrhosis
- Chronic Hepatitis C

## Interventions

- **DIETARY_SUPPLEMENT:** Viusid (nutritional supplement)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00502086
- **Lead sponsor:** Catalysis SL
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2011-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00502086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00502086, "Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection.". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00502086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*